Highly sensitive fluorescence-based lateral flow platform for point-of-care detection of biomarkers in plasma
- 1 November 2017
- conference paper
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 249-252
Abstract
Point-of-Care (PoC) diagnostic devices, such as lateral flow tests, are often used in low and middle-income countries (LMIC) for low-cost disease detection. Most commercial lateral flow tests use colorimetric detection on a nitrocellulose substrate. In this paper, we present a multistep, fluorescence-based assay detection system, which can detect antibodies in plasma to recombinant protein. Fluorescence-based detection allows us to achieve higher sensitivity, while a nitrocellulose substrate enables fluid handling, high protein immobilization, rapid detection time, and affordability. As a proof-of-concept for detection of disease-specific biomarkers in plasma, we demonstrate the detection of antibodies in plasma to Epstein-Barr nuclear antigen-1 (EBNA-1) recombinant protein and to human papillomavirus (HPV) 16 E7 recombinant protein. We show that our detection system is able to detect EBNA-1-specific antibodies at a 1:10,000 plasma dilution and HPV 16 E7-specific antibodies at a 1:5,000 plasma dilution, indicating high sensitivity. This platform is a low-cost device that can detect fluorescence from labeled biomarkers on a lateral flow assay. Ultimately, we aim to adapt this system to detect HPV 16 and 18 biomarkers for cervical cancer screening in LMICs.Keywords
This publication has 8 references indexed in Scilit:
- Characterization of a compact and highly sensitive fluorescence-based detection system for point-of-care applications2016
- Application of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkersScientific Reports, 2016
- Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT studyOral Oncology, 2015
- Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their PartnersJournal of Clinical Oncology, 2014
- Point-of-Care Diagnostics for Global HealthAnnual Review of Biomedical Engineering, 2008
- Routine Epstein-Barr Virus Diagnostics from the Laboratory Perspective: Still Challenging after 35 YearsJournal of Clinical Microbiology, 2004
- Diagnostics for the developing worldNature Reviews Microbiology, 2004
- Protein binding to nitrocellulose, nylon and PVDF membranes in immunoassays and electroblottingJournal of Biochemical and Biophysical Methods, 1989